• About
  • Privacy Policy
  • Terms Of Use
  • Contact
Sunday, February 5, 2023
Pharma Info Nepal
  • Home
  • Loksewa
  • License
  • Questions
  • Vacancy
  • Downloads
  • Notice
No Result
View All Result
  • Home
  • Loksewa
  • License
  • Questions
  • Vacancy
  • Downloads
  • Notice
No Result
View All Result
Pharma Info Nepal
No Result
View All Result
Home Updates

FDA Approved Drugs in 2020

List of FDA Approved Drugs in 2020

Nabin Bista by Nabin Bista
January 2, 2021
in Updates
0
FDA Approved Drugs in 2020
825
VIEWS
Share on FacebookShare on Twitter

FDA Approved Drugs in 2020

This is the world that Corona challenged The pharmacy industry has suffered huge losses. The FDA worked tirelessly, but no medication was approved for Corona. For emergency use, the FDA recommends using remdesivir. Pharmaceutical company worked tirelessly for drug search and vaccine development.

In the year 2020, 53 drugs have been approved by the FDA for various uses

The availability of new drugs and biological products often means new treatment options for patients and advances in health care for all. Because of this, the FDA supports innovation and helps advance new drug development.

Drug NameActive IngredientFDA-approved use on approval date
GemtesavibegronTo treat overactive bladder
Ebanga
ansuvimab-zykl
To treat ebola
OrgovyxrelugolixTo treat advanced prostate cancer
Margenzamargetuximab (anti-HER2 mAbTo treat HER2+ breast cancer
KlisyritirbanibulinTo treat actinic Keratosis of the face or scalp
OrladeyoberotralstatTo treat patients with hereditary angioedema
Gallium 68 PSMA-11Gallium 68 PSMA-11For detection and localization of prostate cancer
Danyelzanaxitamab-gqgkTo treat high-risk refractory or relapsed neuroblastoma
ImcivreesetmelanotideTo treat obesity and the control of hunger associated with pro-opiomelanocortin deficiency, a rare disorder that causes severe obesity that begins at an early age
OxlumolumasiranTo treat hyperoxaluria type 1
ZokinvylonafarnibTo treat rare conditions related to premature aging
VekluryremdesivirTo treat COVID-19
Inmazebatoltivimab, maftivimab, and odesivimab-ebgnTo treat ebola virus
GavretopralsetinibTo treat non-small lung cancer
Detectnetcopper Cu 64 dotatate injectionTo help detect certain types of neuroendocrine tumors
Sogroyasomapacitan-becoGrowth hormone
WinleviclascoteroneTo treat acne
Enspryngsatralizumab-mwgeTo treat neuromyelitis optica spectrum disorder
ViltepsoviltolarsenTo treat Duchenne muscular dystrophy
OlinvykoliceridineTo manage acute pain in certain adults
EvrysdirisdiplamTo treat spinal muscular atrophy
LampitnifurtimoxTo treat Chagas disease in certain pediatric patients younger than age 18
Blenrepbelantamab mafodotin-blmfTo treat multiple myeloma
Monjuvitafasitamab-cxixTo treat relapsed or refractory diffuse large B-cell lymphoma
XeglyzeabametapirTo treat head lice
Inqovidecitabine and cedazuridineTo treat adult patients with myelodysplastic syndromes
RukobiafostemsavirTo treat HIV
ByfavoremimazolamFor sedation
DojolvitriheptanoinTo treat molecularly long-chain fatty acid oxidation disorders
ZepzelcalurbinectedinTo treat metastatic small cell lung cancer
Upliznainebilizumab-cdonTo treat neuromyelitis optica spectrum disorder
Tauvidflortaucipir F18Diagnostic agent for patients with Alzheimer’s disease
ArtesunateartesunateTo treat severe malaria
Ceriannafluoroestrdiol F18Diagnostic imaging agent for certain patients with breast cancer
QinlockripretinibTo treat advanced gastrointestinal-stromal tumors
RetevmoselpercatinibTo treat lung and thyroid cancers
TabrectacapmatinibTo treat patients with non small cell lung cancer
OngentysopicaponeTo treat patients with Parkinson’s disease experiencing “off” episodes
Trodelvysacituzumab govitecan-hziyTo treat adult patients with metastatic triple-negative breast cancer who received at least two prior therapies for metastatic disease
PemazyrepemigatinibTo treat certain patients with cholangiocarcinoma, a rare form of cancer that forms in bile ducts
TukysatucatinibTo treat advanced unresectable or metastatic HER2-positive breast cancer
KoselugoselumetinibTo treat neurofibromatosis type 1, a genetic disorder of the nervous system causing tumors to grow on nerves
ZeposiaozanimodTo treat relapsing forms of multiple sclerosis
IsturisaosilodrostatTo treat adults with Cushing’s disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the disease
SarclisaisatuximabTo treat multiple myloma
Nurtec ODTrimegepantTo treat migraine
BarhemsysamisulprideTo help prevent nausea and vomiting after surgery
Vyeptieptinezumab-jjmrFor the preventive treatment of migraine in adults
Nexletolbempedoic acidTo treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C
PizensylactitolTo treat chronic idiopathic constipation (CIC) in adults
TazveriktazemetostatTo treat epithelioid sarcoma
Tepezzateprotumumab-trbwTo treat Thyroid eye disease
AyvakitavapritinibTo treat adults with unresectable or metastatic gastrointestinal stromal tumor (GIST)

 


  • Banned Drugs in Nepal
  • Top 10 Nepali Pharmaceutical Industry

 

Tags: Pharmacy Updates
Previous Post

Bachelor of Pharmacy(B.Pharm) Curriculum Tribhuvan University IOM 

Next Post

Nepal Pharmacy Council License Exam Model set For Pharmacy Assistant

Nabin Bista

Nabin Bista

Hello, Thank You for visiting my blog I am Nabin Bista, Dedicated and self motivated young Pharmacist from Nepal. Blogging is my passion. I am studying B Pharmacy at Institute of Medicine - IOM. If you want me to write about any posts that you found confusing/difficult, please mention in the comments below.

Related Posts

Pharma Info Nepal | Nepal's No. 1 Pharmacy Blog

Drug and Medicine Related Act, Rules, Regulations, Policies, Guidelines & Directives in Nepal

February 1, 2023
FDA-Approved HIV Medicines

FDA Approved HIV Medicines

January 26, 2023
Combined Oral Contraceptives (COC)

Combined Oral Contraceptives (COC)

January 17, 2023
Novel Drug Approvals for 2022

Novel Drug Approvals for 2022

January 3, 2023
Load More
Next Post
Nepal Pharmacy Council License Exam Model set For Pharmacy Assistant

Nepal Pharmacy Council License Exam Model set For Pharmacy Assistant

Discussion about this post

Recommended

List of Applicants for 16th Name Registration Examination Bachelor in Pharmacy

List of Applicants for 16th Name Registration Examination Bachelor in Pharmacy

2 years ago
List and Price of Medicines and Facilities Available From the Health Insurance Nepal

List and Price of Medicines and Facilities Available From the Health Insurance Nepal

2 years ago

Don't Miss

Ethical Guidelines for the Care and Use of Animals in Health Research in Nepal

Ethical Guidelines for the Care and Use of Animals in Health Research in Nepal

February 4, 2023
Pharma Info Nepal | Nepal's No. 1 Pharmacy Blog

Drug and Medicine Related Act, Rules, Regulations, Policies, Guidelines & Directives in Nepal

February 1, 2023
Vacancy Announcement Assistant Professor Pharmacy and Medicine Dispenser 

Vacancy Announcement Assistant Professor Pharmacy and Medicine Dispenser 

February 1, 2023
FDA-Approved HIV Medicines

FDA Approved HIV Medicines

January 26, 2023

About Pharma Info Nepal

Pharma Info Nepal (Nabin’s Blog) was initiated in 2019 with the aim of providing relevant and accurate information for pharmacy, nursing and other health professionals. Since then it is conveying health related educational and informational updates of Nepal. It serves as a source for learning materials on diverse topics relating to medicine intended basically for pharmacy and nursing students. It covers job opportunities, question collections for pharmacy license, nursing license as well as various competitive exams.

Our readers rely on us for the well referenced and latest updates collected from the reliable sites.

Follow us

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram

Information Reader

Contents (text, image, graphics, documents and other materials) published on this portal are collected from other relevant sources with the sole purpose of sharing information. Contents and features are subject to change and all rights reserved to Pharma info Nepal. The information presented on this web portal and its official social media handles have no affiliation to any organization that author is involved with either professionally or personally.

If you have found anything displayed incorrectly or have further suggestions on improving our effort, please do not hesitate to reach out at pharmainfonepal1@gmail.com !
We hope you find Pharma info Nepal a helpful site. Thanks !!!

Categories

  • B Pharmacy
  • Colleges
  • D Pharmacy
  • Downloads
  • License
  • Loksewa
  • M Pharmacy
  • Medicinal Chemistry
  • Notice
  • Nursing
  • Pharmacognosy
  • Pharmacology
  • Questions
  • Scholarship
  • Study Materials
  • Syllabus
  • Updates
  • Vacancy

DOWNLOADS

Pharmacy Book 

Pharmacy Act and Guidelines

About Pharma Info Nepal

About Admin

  • About
  • Privacy Policy
  • Terms Of Use
  • Contact

© 2021 Nabin's Blog

No Result
View All Result
  • Home
  • Loksewa
  • License
  • Questions
  • Vacancy
  • Downloads
  • Notice

© 2021 Nabin's Blog

error: